Cost and effectiveness of one session treatment (OST) for children and young people with specific phobias compared to multi-session cognitive behavioural therapy (CBT): results from a randomised controlled trial | | 2022 |
The Effect of the Drug Life Cycle Price on Cost-Effectiveness: Case Studies Using Real-World Pricing Data | | 2022 |
Relationship between Serum Ferritin and Outcomes in β-Thalassemia: A Systematic Literature Review | | 2022 |
Health-related quality-of-life and health-utility reporting in critical care | World Journal of Critical Care Medicine | 2022 |
Estimating the impact of changes in weight and BMI on EQ-5D-3L: a longitudinal analysis of a behavioural group-based weight loss intervention | Quality of Life Research | |
Routine fixation of humeral shaft fractures is cost-effective | Bone & Joint Open | 2022 |
Dynamic and Flexible Survival Models for Extrapolation of Relative Survival: A Case Study and Simulation Study | Medical Decision Making | |
Cost-utility analysis of cast compared to removable brace in the management of adult patients with ankle fractures | Bone & Joint Open | 2022 |
Health Economic Analysis of the Integrated Cognitive Assessment Tool to Aid Dementia Diagnosis in the United Kingdom | | |
Local Instrumental Variable Methods to Address Confounding and Heterogeneity when Using Electronic Health Records: An Application to Emergency Surgery | Medical Decision Making | |
Capturing the value of vaccination within health technology assessment and health economics: Country analysis and priority value concepts | Vaccine | 2022 |
Stick or twist? Cost-effectiveness of siponimod compared with continuing existing disease-modifying therapies in the treatment of active secondary progressive multiple sclerosis in the UK. | Journal of Medical Economics | 2022 |
Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score® test in node-positive early breast cancer. | Journal of Medical Economics | 2022 |
The Development of the EQ-5D-5L and its Value Sets | | 2022 |
Challenges in Using Recommended Quality of Life Measures to Assess Fluctuating Health: A Think-Aloud Study to Understand How Recall and Timing of Assessment Influence Patient Responses | Patient | 2021 |
Non-disease specific patient-reported outcome measures of health-related quality of life in juvenile idiopathic arthritis: a systematic review of current research and practice. | Rheumatology International | 2021 |
Out of Date or Best Before? A Commentary on the Relevance of Economic Evaluations Over Time | Pharmacoeconomics | 2021 |
A randomized controlled trial of a proportionate universal parenting program delivery model (E-SEE Steps) to enhance child social-emotional wellbeing. | PLoS ONE | 2022 |
The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson's Disease in England. | Pharmacoeconomics | 2022 |
Capturing what matters: updating NICE methods guidance on measuring and valuing health. | Quality of Life Research | 2022 |
Transarterial Radioembolization Versus Atezolizumab-Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life. | Advances in Therapy | 2022 |
Mid-Term Outcomes of Laparoscopic Gastric Greater Curvature Plication versus Roux-en-Y Gastric Bypass: Weight Loss, Gastrointestinal Symptoms, and Health-Related Quality of Life. | Medicina (Lithuania) | 2021 |
Cost-effectiveness and value of information analysis of NephroCheck and NGAL tests compared to standard care for the diagnosis of acute kidney injury | BMC Nephrology | 2021 |
Cost-effectiveness model of renal cell carcinoma (RCC) surveillance in hereditary leiomyomatosis and renal cell carcinoma (HLRCC). | Journal of Medical Genetics | 2022 |
A Systematic Literature Review of the Relationship between Serum Ferritin and Outcomes in Myelodysplastic Syndromes. | Journal of Clinical Medicine | 2022 |
A pilot economic evaluation of a feasibility trial for SUpporting wellbeing through PEeR-Befriending (SUPERB) for post-stroke aphasia. | Clinical Rehabilitation | 2022 |
Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data. | European Journal of Health Economics | 2022 |
Challenges of modelling approaches for network meta-analysis of time-to-event outcomes in the presence of non-proportional hazards to aid decision making: Application to a melanoma network. | Statistical Methods in Medical Research | 2022 |
Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model. | International Journal of COPD | 2021 |
Children and Young People's Health Partnership Evelina London Model of Care: economic evaluation protocol of a complex system change | BMJ Open | 2021 |
The Cambridge Cognitive and Psychiatric Assessment Kit (CamCOPS): A Secure Open-Source Client-Server System for Mobile Research and Clinical Data Capture | Frontiers in Psychiatry | 2021 |
Steps in implementing a health economic evaluation | RMD Open | 2020 |
Mobile Health App (AGRIPPA) to Prevent Relapse After Successful Interdisciplinary Treatment for Patients With Chronic Pain: Protocol for a Randomized Controlled Trial | JMIR Research Protocols | 2020 |
A Cost-utility Analysis of Endovascular Aneurysm Repair for Abdominal Aortic Aneurysm | The Journal of Japanese College of Angiology | 2016 |
Evaluating quality of life and cost implications of prophylactic radiotherapy in mesothelioma: Health economic analysis of the SMART trial | PLoS ONE | 2018 |
An Introduction to EQ-5D Instruments and Their Applications | | 2020 |
Discrepancies between proxy estimates and patient reported, health related, quality of life: minding the gap between patient and clinician perceptions in heart failure | Quality of Life Research | 2021 |
Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores | Applied Health Economics and Health Policy | 2021 |
Avoiding Opportunity Cost Neglect in Cost-Effectiveness Analysis for Health Technology Assessment | Applied Health Economics and Health Policy | 2021 |
The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom | Human Vaccines and Immunotherapeutics | 2021 |
What Aspects of Illness Influence Public Preferences for Healthcare Priority Setting? A Discrete Choice Experiment in the UK | Pharmacoeconomics | 2021 |
Costs and Cost-Effectiveness of User-Testing of Health Professionals' Guidelines to Reduce the Frequency of Intravenous Medicines Administration Errors by Nurses in the United Kingdom: A Probabilistic Model Based on Voriconazole Administration | Applied Health Economics and Health Policy | 2021 |
Development and Validation of a Preference-Based Glaucoma Utility Instrument Using Discrete Choice Experiment | JAMA Ophthalmology | 2021 |
Early detection of neovascular age-related macular degeneration: an economic evaluation based on data from the EDNA study | British Journal of Ophthalmology | 2021 |
Reference data among general population and known-groups validity among hypertensive population of the EQ-5D-5L in Vietnam | Quality of Life Research | 2021 |
Cost-effectiveness of procedure-less intragastric balloon therapy as substitute or complement to bariatric surgery | PLoS ONE | 2021 |
Cost-effectiveness of surgery versus cast immobilization for adults with a bicortical fracture of the scaphoid waist : an economic evaluation of the SWIFFT trial | Bone and Joint Journal | 2021 |
The Cost-Effectiveness of Expanding Vaccination with a Cell-Based Influenza Vaccine to Low Risk Adults Aged 50 to 64 Years in the United Kingdom | Vaccines | 2021 |
Neutral theory: applicability and neutrality of using generic health-related quality of life tools in diseases or conditions where specific tools are available | BMC Medical Research Methodology | 2021 |
Plate fixation of midshaft clavicle fractures for delayed union and non-union is a cost-effective intervention but functional deficits persist at long-term follow-up | Shoulder and Elbow | |
Modeling long-term health and economic implications of new treatment strategies for Parkinson's disease: an individual patient simulation study | Journal of Market Access & Health Policy | 2021 |
Value-based payment models involving pharmaceutical services | | 2021 |
Economic Evaluations of Gestational Diabetes Mellitus Screening: A Systematic Review | Journal of Epidemiology | 2021 |
Is Protocolised Weaning that Includes Early Extubation Onto Non-Invasive Ventilation More Cost Effective Than Protocolised Weaning Without Non-Invasive Ventilation? Findings from the Breathe Study | PharmacoEconomics - Open | 2020 |
The validation of published utility mapping algorithms: an example of EORTC QLQ-C30 and EQ-5D in non-small cell lung cancer | Health Economics Review | 2020 |
Mapping the EORTC QLQ-C30 and QLQ-H&N35, onto EQ-5D-5L and HUI-3 indices in patients with head and neck cancer | Head and Neck | 2020 |
Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States | Pharmacoeconomics | 2020 |
Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting: the SCOOP study | Osteoporosis International | 2020 |
Whom should we ask? A systematic literature review of the arguments regarding the most accurate source of information for valuation of health states | Quality of Life Research | 2020 |
Use of Patient Preference Studies in HTA Decision Making: A NICE Perspective | Patient | 2020 |
Challenges of Systematic Reviews of Economic Evaluations: A Review of Recent Reviews and an Obesity Case Study | Pharmacoeconomics | 2020 |
An Economic Evaluation of Voretigene Neparvovec for the Treatment of Biallelic RPE65-Mediated Inherited Retinal Dystrophies in the UK | Advances in Therapy | 2020 |
The clinical and cost-effectiveness of supplemental parenteral nutrition in oncology | ESMO Open | 2020 |
Cost-effectiveness analysis of ocriplasmin versus watchful waiting for treatment of symptomatic vitreomacular adhesion in the US | Journal of Comparative Effectiveness Research | 2020 |
Parkinson's disease with early motor complications: predicting EQ-5D- 3L utilities from PDQ-39 data in the EARLYSTIM trial | Health and Quality of Life Outcomes | 2020 |
Cost-Effectiveness Analysis of Sequential Biologic Therapy with Ixekizumab Versus Secukinumab in the Treatment of Active Psoriatic Arthritis with Concomitant Moderate-to-Severe Psoriasis in the UK | PharmacoEconomics - Open | 2020 |
An EQ-5D-5L Value Set for Vietnam | Quality of Life Research | 2020 |
Enhanced recovery following hip and knee arthroplasty: a systematic review of cost-effectiveness evidence | BMJ Open | 2020 |
Economic evaluation alongside the Speed of Increasing milk Feeds Trial (SIFT) | Archives of Disease in Childhood: Fetal and Neonatal Edition | 2020 |
Cytoreductive surgery (CRS) with hyperthermic intraoperative peritoneal chemotherapy (HIPEC) versus standard of care (SoC) in people with peritoneal metastases from colorectal, ovarian or gastric origin: protocol for a systematic review and individual participant data (IPD) meta-analyses of effectiveness and cost-effectiveness | BMJ Open | 2020 |
Which interactions matter in economic evaluations? A systematic review and simulation study | BMC Medical Research Methodology | 2020 |
An individually randomised controlled multi-centre pragmatic trial with embedded economic and process evaluations of early vocational rehabilitation compared with usual care for stroke survivors: study protocol for the RETurn to work After stroKE (RETAKE) trial | Trials | 2020 |
Some reflections on the use of inappropriate comparators in CEA | Cost Effectiveness and Resource Allocation | 2020 |
EQ-5D-3L health status and health state utilities of the oldest-old (85 +) in Germany: results from the AgeCoDe-AgeQualiDe study | Quality of Life Research | 2020 |
Cost-benefit analysis of surveillance for surgical site infection following caesarean section | BMJ Open | 2020 |
FIRST-line support for assistance in breathing in children (FIRST-ABC): a master protocol of two randomised trials to evaluate the non-inferiority of high-flow nasal cannula (HFNC) versus continuous positive airway pressure (CPAP) for non-invasive respiratory support in paediatric critical care | BMJ Open | 2020 |
Using qualitative methods for a conceptual analysis of measures of health status and presenteeism prior to a mapping study | Quality of Life Research | 2020 |
The Forearm Fracture Recovery in Children Evaluation (FORCE) trial: statistical and health economic analysis plan for an equivalence randomized controlled trial of treatment for torus fractures of the distal radius in children | Bone & Joint Open | 2020 |
A comparison of partitioned survival analysis and state transition multi-state modelling approaches using a case study in oncology | Journal of Medical Economics | 2020 |
Cost Effectiveness of Teplizumab for Prevention of Type 1 Diabetes Among Different Target Patient Groups | Pharmacoeconomics | 2020 |
Costs of joint replacement in osteoarthritis: a study using the National Joint Registry and Clinical Practice Research Datalink datasets | Arthritis Care and Research | 2020 |
Protocol for the economic evaluation of metacognitive therapy for cardiac rehabilitation participants with symptoms of anxiety and/or depression | BMJ Open | 2020 |
Mapping the University of Washington Quality of life questionnaire onto EQ-5D and HUI-3 indices in patients with head and neck cancer | Head and Neck | 2020 |
How Uncertain is the Survival Extrapolation? A Study of the Impact of Different Parametric Survival Models on Extrapolated Uncertainty About Hazard Functions, Lifetime Mean Survival and Cost Effectiveness | Pharmacoeconomics | 2020 |
How should we assess the clinical and cost effectiveness of histology independent cancer drugs? | BMJ, The | 2020 |
Detachable low dead space syringes for the prevention of hepatitis C among people who inject drugs in Bristol, UK: an economic evaluation | Addiction | 2020 |
Cost-effectiveness of e-cigarettes compared with nicotine replacement therapy in stop smoking services in England (TEC study): a randomized controlled trial | Addiction | 2020 |
A quality-of-life mapping function developed from a grass pollen sublingual immunotherapy trial to a tree pollen sublingual immunotherapy trial | Journal of Medical Economics | 2020 |
Cost Effectiveness of PD-L1-Based Test-and-Treat Strategy with Pembrolizumab as the First-Line Treatment for Metastatic NSCLC in Hong Kong | PharmacoEconomics - Open | 2020 |
Influence of elicitation procedure and phrasing on health state valuations in experience-based time trade-off tasks among diabetes patients in China | Quality of Life Research | 2020 |
Conducting a Time Trade-Off Study Alongside a Clinical Trial: A Case Study and Recommendations | PharmacoEconomics - Open | 2019 |
Ibrutinib for Treating Relapsed or Refractory Mantle Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal | Pharmacoeconomics | 2019 |
Sensitivity of EQ-5D-3L, HUI2, HUI3, and SF-6D to changes in speech reception and tinnitus associated with cochlear implantation | Quality of Life Research | 2019 |
Mapping the Positive and Negative Syndrome Scale scores to EQ-5D-5L and SF-6D utility scores in patients with schizophrenia | Quality of Life Research | 2019 |
On estimands and the analysis of adverse events in the presence of varying follow-up times within the benefit assessment of therapies | Pharmaceutical Statistics | 2019 |
Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma : An Evidence Review Group Evaluation of the NICE Single Technology Appraisal | Pharmacoeconomics | 2019 |
Cost-effectiveness of prenatal screening and diagnostic strategies for Down syndrome: A microsimulation modeling analysis | PLoS ONE | 2019 |
Towards UK poSt Arthroplasty Follow-up rEcommendations (UK SAFE): protocol for an evaluation of the requirements for arthroplasty follow-up, and the production of consensus-based recommendations | BMJ Open | 2019 |
Is the Validity of Cost Utility Analysis Improved When Utility is Measured by an Instrument with ‘Home-Country’ Weights? Evidence from Six Western Countries | Social Indicators Research | 2019 |
A brief introduction to health economics | Knee Surgery, Sports Traumatology, Arthroscopy | 2019 |